Otilimab, CAS 1638332-55-4

Product Description: Otilimab (GSK 3196165) is an anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) human monoclonal antibody. Otilimab neutralises the biological function of GM-CSF by blocking the interaction of GM-CSF with its cell surface receptor[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Senolt L. Emerging therapies in rheumatoid arthritis: focus on monoclonal antibodies. F1000Res. 2019 Aug 30;8:F1000 Faculty Rev-1549.

CAS Number: 1638332-55-4

Molecular Weight: N/A

Compound Purity: 95.0

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: c-Fms

• Artikelnummer: MEXHY-P99795-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99795-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated